Personalized Treatment of Refractory BPPV

Recruiting N/A Interventional Study
Benign Paroxysmal Positional Vertigo Personalized Medicine
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
54 (estimated)
Sponsor
Hospital Clinico Universitario de Santiago · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo, often effectively treated with standard canalith repositioning maneuvers (CRMs). However, approximately 12.5% of cases remain refractory, leading to persistent symptoms and increased healthcare burden. Variations in the anatomical orientation of the semicircular canals (SCCs) may explain the resistance to …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * A. Diagnosed with BPPVp according to the Barany Society criteria: 1. Recurrent episodes of vertigo or positional instability, triggered by lying down or turning the head in the supine position. 2. Episodes lasting less than 1 minute. 3. Positional nystagmus observed aft…
Contacts

Andrés Soto-Varela, Prof, PhD

+34981951157

andres.soto.varela@sergas.es

CONTACT

Ismael Arán-Tapia, PhD

+34663654574

ismaelaran.tapia@usc.es

CONTACT